Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GENTEX CORP Director's Dealing 2018

Jan 31, 2018

30893_dirs_2018-01-31_f7557a96-a0dc-4313-ba79-9bfbf39fcd62.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2018-01-30

Reporting Person: Nash Kevin C (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-01-30 Common Stock M 3330.00 $12.795 Acquired 34062.00 Direct
2018-01-30 Common Stock M 1612.00 $15.50 Acquired 35674.00 Direct
2018-01-30 Common Stock M 2932.00 $13.385 Acquired 38606.00 Direct
2018-01-30 Common Stock S 7874.00 $23.4039 Disposed 30732.00 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-01-30 Employee Stock Option (Right to buy) $15.50 M 1612.00 Disposed 2022-09-30 Common Stock (1612.00) Direct
2018-01-30 Employee Stock Option (Right to buy) $13.385 M 2932.00 Disposed 2021-09-30 Common Stock (2932.00) Direct
2018-01-30 Employee Stock Option (Right to buy) $12.795 M 3330.00 Disposed 2018-09-30 Common Stock (3330.00) Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $23.40 to $23.42. The price reported above reflects the weighted average price.

F2: These shares become exercisable as to 20% one year after date of grant and an additional 20% at each ensuing anniversary date.

F3: These shares become exercisable as to 25% one year after date of grant and an additional 25% at each ensuing anniversary date.